Kuvura kanseri mito y'ibihaha

Amahitamo yo kwivuza nibiciro kubihumyo bito bya kanseri ya Kanseri ya Kanseri y'ibihaha (SCLC) ni ubwoko bwa kanseri y'ibihaha bisaba kuvurwa byihuse kandi neza. Gusobanukirwa ibyawe Amahitamo yo kuvura kandi bifitanye isano ibiciro ni ngombwa kubera gufata ibyemezo. Aka gatabo gatanga incamake yuzuye ya therapies nibitekerezo bitera amafaranga yabo.

Gusobanukirwa kanseri ntoya y'ibihaha

Gusuzuma no Gukoresha

Gusuzuma neza kwa SCLC bishingiye ku buryo butandukanye, harimo n'ibizamini byamashusho (CT Scan, scan), ibinyabuzima byayo, n'ibizamini byamaraso. STANDA igena urugero rwa kanseri ikwirakwira, kugira ngo ihindure amahitamo yo kuvura no gukomera. Gusuzuma kare biteza imbere cyane ingaruka zavuwe. Icyiciro cya kanseri yawe kizagira ingaruka cyane Kuvura kanseri mito y'ibihaha.

Intego zo kuvura

Kuvura kanseri ntoya y'ibihaha Intego yo kuruhuka, bivuze ko kanseri idakosowe, cyangwa byibuze yagabanutse cyane. Ku barwayi benshi, intego ni ukugera ku kurwanya indwara igihe kirekire no kuzamura imibereho.

Amahitamo mato ya selile

Chimiotherapie

Chimiotherapie ni imfuruka ya sclc kuvura, akenshi ikoreshwa nkuburyo bwambere. Bikunze gukoreshwa ibiyobyabwenge harimo Cisplatin na ETopode, akenshi bitangwa hamwe. The Igiciro cya Chemotherapie Biratandukanye bitewe nibiyobyabwenge byihariye byakoreshejwe, igihe cyo kuvura, hamwe nubwubuvuzi.

Imivugo

Umuyoboro w'imirasire ukoresha imirasire y'ingufu nyinshi ku ntego no gusenya ingirabuzimafatizo. Bikunze gukoreshwa hamwe na chimiotherapie, cyane cyane kubwindwara zaho. The Igiciro cyo kuvura imirasire ni Byatewe nibintu nkubuvuzi, umubare wamasomo, hamwe nubuhanga bwimirasire yihariye bukoreshwa.

IGITABO

Abashushanya intego bibanda kuri moleki zihariye mu kagari ka kanseri, kubangamira gukura kwabo no kubaho. Mugihe atari byo bikoreshwa cyane muri SCLC nko muri kanseri idafite kanseri ntoya (NSCLC), bamwe mu bakozi bagenewe bagaragaza amasezerano. The Igiciro cya THERAPY akenshi byerekana imiterere yateye imbere yiyi miti.

Impfuya

Umuvumo wibiryo byumubiri wumubiri wumubiri wo kurwanya kanseri. Ababuza bariyeri, nka Pembezimab, barimo gukorwaho iperereza kubera uruhare bagize muri SCLC. The Igiciro cya ImmUnotherapy muri rusange biri hejuru kubera ibintu bigoye.

Kubaga

Kubaga ntibikoreshwa nkibintu byibanze bya SCLC kubera impengamiro yacyo yo gukwirakwira vuba. Ariko, irashobora gufatwa nkimpamvu nkeya, indwara yambere. The Igiciro cyo kubaga Kuri SCLC, mugihe bibaye ngombwa, bikubiyemo ibizamini byabanjirije gukora, uburyo bwo kubaga ubwabwo, hamwe na nyuma yo kwitaba.

Ibintu bigira ingaruka ku giciro cya kanseri mito y'ibihaha

The Igiciro cya kanseri mito y'ibihaha irahinduka cyane kandi biterwa nibintu byinshi:

Ikintu	Ingaruka ku giciro
Ubwoko bwo kuvura	Chimitherapie muri rusange ihenze kuruta kuvura cyangwa kudahindura impindushyi.
Igihe cyo kuvura	Amasomo maremare asanzwe yiyongera muri rusange.
Utanga Ubuzima	Amafaranga arashobora gutandukana cyane bitewe nibitaro cyangwa kuvura.
Ubwishingizi	Gahunda yubwishingizi irashobora kugabanya cyane amafaranga yo hanze.
Ahantu	Ibiciro byo kuvura bitandukanya geografiya.

Kubona Inkunga n'umutungo

Kuyobora ibintu bigoye bya sclc nacyo Amahitamo yo kuvura agura birashobora kuba byinshi. Amashyirahamwe menshi atanga inkunga n'umutungo ku barwayi n'imiryango yabo. Tekereza uburyo bwo gushakisha nk'amatsinda ashyigikira, gahunda zifasha mu mafaranga, n'ibigeragezo by'amavuriro. Kubindi bisobanuro birambuye kuri kanseri kuvura kanseri, ushobora gusanga amikoro kuri Shandong Baofa Kanseri Ikigo cyubushakashatsi bifasha. Bashobora gutanga ubundi bushishozi mumateraniro aheruka mu kuvura na SCLC kandi amafaranga ajyanye. Wibuke guhora ugisha inama yikipe yawe yubuvuzi kugirango ushyireho gahunda yo kuvura yihariye ihuza ibikenewe byihariye nubukungu.Ibibazo. Buri gihe ujye ubaza umuganga wawe cyangwa abandi barwanyi babishoboye kubibazo byose ushobora kuba ufite kubijyanye nubuvuzi cyangwa uburyo bwo kuvura. Ibiciro byavuzwe kandi birashobora gutandukana cyane bitewe nibintu byavuzwe haruguru.